Zobrazeno 1 - 6
of 6
pro vyhledávání: '"H Quiros Ambel"'
Autor:
AA García Sacristán, S Gonzalez Suarez, AR Rubio Salvador, R López Álvarez, P Moya Gómez, A Dominguez Barahona, H Quiros Ambel, C Blázquez Romero
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Infectious diseases are one of the most frequent reasons for consultation in the Emergency Department (ED), as well as one of the main causes of mortality and admission in the hospital. According to recent studies, antimicrobials are the s
Autor:
H Quiros Ambel, P López Sánchez, A Dominguez Barahona, P Moya Gómez, JM Martínez Sesmero, AA García Sacristán, S Gonzalez Suarez
Publikováno v:
Eur J Hosp Pharm
Background Multiple sclerosis (MS) is a chronic neurological disease that carries important personal, social and economic consequences for patients and their environment. Hospital pharmacists are responsible for effective and safe use of drugs, but a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc75b03185bc418fe22fc4f4c2949ebe
https://europepmc.org/articles/PMC7535601/
https://europepmc.org/articles/PMC7535601/
Autor:
FJ Manzano Lista, A Dominguez Barahona, P Moya Gómez, JM Martínez-Sesmero, AA García Sacristán, H Quiros Ambel, S Gonzalez Suarez
Publikováno v:
Eur J Hosp Pharm
Background The use of direct-acting antivirals (DAAs) in hepatitis C virus (HCV) patients has been a controversial issue over the past years in medicine. It has changed the HCV treatment paradigm, becoming a disease that can be cured. An extensive li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf37fbb8bad671deab4f0de2ea6ea3fe
https://europepmc.org/articles/PMC7535248/
https://europepmc.org/articles/PMC7535248/
Autor:
JM Martínez-Sesmero, P Moya Gómez, A Gonzalez Cantero, FJ Manzano Lista, H Quiros Ambel, AA García Sacristán
Publikováno v:
Clinical pharmacy.
Background Apremilast is the first oral selective inhibitor of phosphodiesterase 4 (PDE4) indicated for adults with active psoriatic arthritis (PsA) and moderate to severe plaque psoriasis (Pso). Pso and PsA are chronic disorders with significant mor
Autor:
H Quiros Ambel, A Dominguez Barahona, C Blázquez Romero, N Labrador Andujar, P Moya Gómez, AA García Sacristán, FJ Manzano Lista, JM Martínez Sesmero
Publikováno v:
Drug information and pharmacotherapy.
Background One of the main objectives in the adequacy of HIV antiretroviral treatment is to find the drug or set of drugs that allow the best results to be obtained for the patient and to try to support this medication over time. Since the introducti
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.